An update of the QOF indicator list by NICE suggests that eight new diabetes indicators should be added to QOF from 2019/20. NICE says that the new approach, which comes following a review of the QOF in England, will improve outcomes and decrease the risk of harm from over-treatment.
The online medical learning company The Sound Doctor has launched a new diabetes library which adds to its existing website-based collection of short films for patients.
In May 2009, NICE published recommendations on the use of newer agents for the control of blood glucose in type 2 diabetes. This guideline provides a partial update for NICE Clinical Guideline 66 on the management of type 2 diabetes that was published last year. These newer agents include the dipeptidyl peptidase-4 (DPP-4) inhibitors, thiazolidinediones (TZDs), the glucagon-like peptide-1 (GLP-1) mimetic exenatide and the long-acting insulin analogues (insulin detemir and insulin glargine).
The Royal College of General Practitioners (RCGP) has released an online course exploring low glycaemic-index (GI) diets in type 2 diabetes. The 30-minute e-learning module ‘Type 2 Diabetes – a Low GI Approach’ is aimed at GPs, practice nurses, diabetes specialists nurses and other healthcare professionals working in primary care interested in helping people living with type 2 diabetes.
A new handheld imaging device called MolecuLight i:X has been launched by Smith and Nephew to improve decision making in wound care. The device allows doctors or nurses to improve wound assessments by accurately measuring the presence and distribution of potentially harmful bacteria.
Drugs used to treat diabetes could also be used to treat Alzheimer’s disease, and vice versa, according to new basic research from the University of Aberdeen. This is also the first study of its kind to show that Alzheimer’s disease can lead to diabetes, as opposed to diabetes occurring first as was previously thought.